retatrutide triple agonist glp-1 gip glucagon ly3437943 Retatrutide: How GLP-1/GIP/Glucagon Receptor Agonism Differs From Existing Compounds Retatrutide Research: Triple Agonist Mechanism
Description
If you're not already using a continuous glucose monitoring system, ask your doctor about whether you're eligible to make the switch

Glucagon-like peptide-1 (GLP-1) is a hormone produced by the small intestine, which is responsible for triggering the pancreas to release insulin, blocking the secretion of another hormone called glucagon, slowing digestion, and making you feel full after eating

Taking your injection on Tuesday instead of Thursday means your body receives a continuous signal without significant interruption

Q: What symptoms suggest my dry mouth needs medical evaluation
These are FDA-approved for the treatment of type 2 diabetes and chronic weight management, respectively

May also play a role in how efficiently the body processes nutrients
